Absorption, distribution and elimination of 14 C-amiloride in normal human subjects.
作者信息
Grayson M F, Smith A J, Smith R N
出版信息
Br J Pharmacol. 1971 Oct;43(2):473P-474P.
Abstract
摘要
相似文献
1
Absorption, distribution and elimination of 14 C-amiloride in normal human subjects.14C-氨氯地平在正常人体受试者中的吸收、分布和消除。
Br J Pharmacol. 1971 Oct;43(2):473P-474P.
2
Kinetics and bioavailability of two formulations of amiloride in man.氨氯吡咪两种制剂在人体中的动力学和生物利用度
Br J Pharmacol. 1973 Aug;48(4):646-9.
3
[Renal uptake and intrarenal distribution of amiloride].[氨氯吡咪的肾脏摄取及肾内分布]
Res Exp Med (Berl). 1973 Jul 26;161(1):21-9. doi: 10.1007/BF01851019.
4
Binding sites for amiloride and guanethidine in human blood platelets.人血小板中阿米洛利和胍乙啶的结合位点。
J Physiol. 1969 Jul;203(1):63P-65P.
5
[Clinico-pharmacological studies on drug absorption in liver diseases].[肝脏疾病中药物吸收的临床药理学研究]
Verh Dtsch Ges Inn Med. 1968;74:1138-40.
6
Renal tubule transport and electrolyte effects of amiloride in the chicken.氨氯地平对鸡肾小管转运及电解质的影响。
J Pharmacol Exp Ther. 1981 Nov;219(2):435-41.
7
Role of drug metabolism in drug research and development: basic considerations.药物代谢在药物研发中的作用：基本考量
J Pharm Sci. 1972 Oct;61(10):1674-7. doi: 10.1002/jps.2600611039.
8
Kinetic analysis of the amiloride-sodium entry site interaction in rabbit colon.
Mol Pharmacol. 1981 Nov;20(3):543-50.
9
New drugs--no. 9, amiloride hydrochloride.新药——第9号，盐酸阿米洛利。
J Ir Med Assoc. 1973 Sep 15;66(17):487.
10
Amiloride handling in renal failure.肾衰竭时氨氯吡咪的处理
Br J Clin Pharmacol. 1980 Jan;9(1):94-5. doi: 10.1111/j.1365-2125.1980.tb04803.x.
引用本文的文献
1
Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.阿米洛利减少肾小球蛋白尿中尿激酶/纤溶酶原驱动的管腔内补体激活。
J Am Soc Nephrol. 2024 Apr 1;35(4):410-425. doi: 10.1681/ASN.0000000000000312. Epub 2024 Jan 23.
2
Amiloride: biological fluid analysis by reverse-phase HPLC.阿米洛利：反相高效液相色谱法的生物流体分析。
Pharm Res. 1985 May;2(3):143-5. doi: 10.1023/A:1016371618594.
3
K+ secretion in the rat kidney: Na+ channel-dependent and -independent mechanisms.大鼠肾脏中的钾离子分泌：依赖钠离子通道和不依赖钠离子通道的机制。
Am J Physiol Renal Physiol. 2009 Aug;297(2):F389-96. doi: 10.1152/ajprenal.90528.2008. Epub 2009 May 27.
4
Bioavailability prediction based on molecular structure for a diverse series of drugs.基于分子结构对多种药物进行生物利用度预测。
Pharm Res. 2004 Jan;21(1):68-82. doi: 10.1023/b:pham.0000012154.09631.26.
5
Short term effects and urinary excretion of the new diuretic, indapamide, in normal subjects.
Eur J Clin Pharmacol. 1974 Oct 4;7(6):407-14. doi: 10.1007/BF00560352.
6
Limitation on the use of amiloride in early renal failure.早期肾衰竭中使用氨氯吡咪的限制。
Eur J Clin Pharmacol. 1985;28(1):61-6. doi: 10.1007/BF00635709.
7
Pharmacokinetics of amiloride in renal and hepatic disease.
Eur J Clin Pharmacol. 1987;33(5):493-8. doi: 10.1007/BF00544242.
8
Diuretics: mechanism of action and clinical application.利尿剂：作用机制与临床应用
Drugs. 1975;9(3):178-226. doi: 10.2165/00003495-197509030-00003.
本文引用的文献
1
2
The meetabolism of amiloride hydroloride in man.盐酸阿米洛利在人体内的代谢。
Clin Pharmacol Ther. 1969 May-Jun;10(3):401-6. doi: 10.1002/cpt1969103401.
3
Effects of amiloride on active sodium transport by the isolated frog skin: evidence concerning site of action.氨氯吡咪对离体蛙皮主动钠转运的作用：关于作用部位的证据
Br J Pharmacol. 1970 Apr;38(4):702-18. doi: 10.1111/j.1476-5381.1970.tb09878.x.
Zotero 插件